Affiliation:
1. All authors: The University of Chicago, Chicago, IL.
Abstract
Comparative effectiveness research (CER) has been promoted as a way to improve the translation gap between clinical research and everyday clinical practice as well as to deliver more cost-effective health care. CER will account for a significant portion of funding allocated by the US government for health care research. Oncology has a rich history of improving clinical outcomes and advancing research through randomized controlled trials (RCTs). In this article, we review the role of RCTs in achieving the goals of CER, with particular emphasis on the role of publicly funded clinical trials.
Publisher
American Society of Clinical Oncology (ASCO)
Reference36 articles.
1. Initial National Priorities for Comparative Effectiveness Research 2009 Institute of Medicine: Washington, DC National Academies Press
2. Five Next Steps for a New National Program for Comparative-Effectiveness Research
3. Prioritizing Comparative-Effectiveness Research — IOM Recommendations
4. A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program 2010 Institute of Medicine: Washington, DC National Academies Press
5. Effectiveness of Bevacizumab With First-Line Combination Chemotherapy for Medicare Patients With Stage IV Colorectal Cancer
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献